Related Experiment Videos
MR imaging-guided axillary node biopsy for breast cancer: initial findings
Takuji Yamagami1, Sachiko Yuen, Kiyoshi Sawai
1Department of Radiology, Kyoto Prefectural University of Medicine, 465 Kajii, Kawaramachi-Hirokoji, Kamigyo, 602-8566 Kyoto, Japan. yamagami@koto.kpu-m.ac.jp
European Radiology
|June 13, 2003
Summary
This study shows that MR imaging-guided sentinel node needle biopsy is a feasible method for breast cancer diagnosis. It accurately identifies sentinel nodes and aids in precise malignancy diagnosis without surgery.
Area of Science:
- Oncology
- Radiology
- Surgical Pathology
Background:
- Accurate staging of breast cancer is crucial for treatment planning.
- Sentinel lymph node biopsy is a standard procedure for axillary staging.
- Minimally invasive techniques for sentinel node biopsy are under development.
Purpose of the Study:
- To evaluate the usefulness and feasibility of a novel preoperative sentinel node needle biopsy technique.
- To assess the diagnostic accuracy of MR imaging-guided sentinel node biopsy in breast cancer patients.
- To compare MR imaging-guided biopsy results with operative diagnosis.
Main Methods:
- Developed and utilized a preoperative sentinel node needle biopsy method guided by open MR imaging.
- Nine patients with non-palpable axillary lymph nodes and breast cancer underwent the procedure.
- Sentinel nodes were identified using CT and MR imaging prior to biopsy.
Main Results:
- Sentinel nodes were successfully identified in all 9 patients.
- Sufficient tissue for pathological evaluation was obtained in 77.8% (7/9) of patients.
- Malignancy was precisely diagnosed in 66.7% (6/9) of patients.
- No serious complications were reported.
Conclusions:
- Preoperative MR imaging-guided sentinel node needle biopsy is a feasible and potentially precise diagnostic method for breast cancer.
- This technique shows promise for determining sentinel node malignancy status without resorting to surgery.
- Further research is warranted to validate these findings in larger cohorts.